Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Max Pruetzel-Thomas

Advertisement
Set Alert for Articles By Max Pruetzel-Thomas

Latest From Max Pruetzel-Thomas

Henry Schein expands in UK

The veterinary product distributor Henry Schein has acquired a leading provider of surgical instruments and implants in the UK. The company has bought Sheffield-based Veterinary Instrumentation for an undisclosed sum.

Equipment & Technology Henry Schein

French vets to cut antibiotic use

French veterinary unions have agreed to reduce the quantity of antibiotics their members prescribe ahead of the introduction of a government plan to lower antibiotic use nationwide. The French Federation of Veterinary Syndicates (FSVF) says it will focus on reducing the prescription of oral antibiotics, particularly for preventive use.

Policy & Regulation France

Dechra offers CPD on canine Cushing's

Dechra Veterinary Products will hold a series of continuous professional development (CPD) events for British vets focusing on canine hyperadrenocorticism, or Cushing's syndrome.

Canine Dechra Pharmaceuticals

US approval for Easotic

The US Food and Drug Administration has approved Virbac's treatment for canine ear infections, Easotic. The prescription-only product contains hydrocortisone aceponate, miconazole and gentamycin, and is indicated for the treatment of otitis externa caused by the yeast Malassezia pachydermatis and the bacterium Staphylococcus pseudintermedius. It is applied topically to the ear at a dosage of 1 ml daily for five days. Virbac launched Easotic in Europe in 2009, where it is supplied with a pump applicator.

Canine Policy & Regulation

Evonik builds €500m methionine plant

Evonik is building a €500 million ($650 million) plant in Singapore to produce the amino acid methionine. The investment is its largest to date, and will help the German specialty chemicals company strengthen its core animal nutrition business.

Feed & Additives Germany

Putney hires VP of strategic portfolio planning

The US pet generics company Putney has hired Ted Smolenski as vice-president of strategic portfolio planning. He will lead the company's efforts to expand its product range by recommending drugs for development, license or acquisition.

Policy & Regulation Generics
See All
Advertisement
UsernamePublicRestriction

Register